Search results

Selected filters:

Life Sciences
News

Article type

Topic

Sector

Regions

Year

121 results found for your search

Sort options
26 November 2018

Pharma patent owners in the US are under pressure like they have never been before

Life sciences IP is on the front line as American consumers, legislators and the Trump administration kick back against the high cost of medicines. Reform campaigners say they have never been more confident of change.

25 November 2018

Patent sales on the rise; Microsoft’s deal with Chinese drone company; a deep dive into Oppo’s portfolio; IP insurance goes mainstream; and much more

Your essential Sunday reading: a summary of all the stories posted on the IAM platform in the past week - as well as links to each one

19 November 2018

Dosage patents come under scrutiny at UK Supreme Court

Justices today considering a much-anticipated case whose outcome could make it harder for pharma companies to obtain such protection in the future

15 November 2018

Congress needs role in key patent reform debates, says senior GOP legislator

Tipped to be the ranking Republican on the House Judiciary Committee, Doug Collins looks set to emerge as one of most powerful IP policy voices on Capitol Hill

15 November 2018

The big life sciences IP developments from October 2018

Cannabis patent war looming, “New NAFTA” set to benefit biopharma innovators, a blow for medical device inventors at the CJEU, and much more in this round-up of October’s big life sciences IP news

14 November 2018

UK Supreme Court rejects Warner-Lambert’s pregabalin appeal

Company now faces possibility of £500 million pay-out to the NHS, while ruling could also make second medical use patents harder to obtain and easier to invalidate

07 November 2018

Following US mid-terms don't expect big patent moves in DC, but the life sciences industries should beware

A split Congress and a USPTO director looking to rebalance the system probably rule out further legislative reform, but pharma may be vulnerable to moves related to pricing issues 

26 October 2018

Australian firms play smart with limited patent resources

At IPBC Australasia in Melbourne, in-house leaders discuss patent reform, doing more with less,  and using IP to attract investment.

22 October 2018

Latest EPO Guidelines bring substantial revisions, with CIIs a major focus 

New edition will be effective from 1st November. As well as software-related topics, it covers issues such as unity of inventions, biological processes and changes to oral and opposition proceedings

17 October 2018

CRISPR: the anatomy of a patent landscape

A deep dive into a potentially game-changing technology provides important insights not only for patent professionals, but also for their colleagues in various other business-critical roles

14 October 2018

The big life sciences IP developments in September

In our latest monthly round-up of patent news from the life sciences – covering September - we report on a crucial CRISPR win for the Broad Institute, the launch of WIPO’s new pharma patent database, important judicial comings goings in the District of Delaware, and a whole lot more besides

01 October 2018

Yes, PTAB proceedings against Orange Book patents are on the up. No, they’re not wiping them out

New research confirms that IPR challenges to life sciences patents have increased in recent years, but the data suggests that their effect on commercially important rights is limited

27 September 2018

New generation in SCOTUS and other US courts may mean more patent erosion, says CAFC justice

In keynote IPO speech, Kathleen O’Malley states that in the digital age judicial respect for IP is waning, but argues that rights holders can fight back through improved prosecution and enforcement

13 September 2018

<strong>Chinese biotech patents fail to make mark, more litigation for AbbVie, AIDS Heath Foundation appeals to SCOTUS and much more</strong>

The August edition of our monthly round-up of the life sciences stories you need to know

09 August 2018

US pharma companies under increasing legislative pressure, key EU SPC decision and much more in July’s life sciences IP round-up

In this month’s round-up of patent news from the life sciences, we report on the latest blow to the St Regis Mohawks’ attempt shield their Restasis patents from inter partes review, the new bill seeking to roll out compulsory licensing in the US,…